Intravascular brachytherapy
Medical Services Advisory Committee
Record ID 32003000103
English
Authors' objectives:
This report aims to address the following questions:
- What is the value of catheter-based intravascular brachytherapy (IVB) in addition to percutaneous intervention in the treatment of patients with in-stent restenosis following previous coronary interventions compared with percutaneous intervention only?
- What is the value of using radioactive stents in addition to percutaneous intervention in the treatment of patients with in-stent restenosis following previous coronary interventions compared with percutaneous intervention only? As the use of radioactive stents is expected to be quite limited in clinical practice, this question is included for the sake of completeness, although the lower priority of radioactive stents should be noted.
Authors' recommendations:
MSAC recommends that, on the strength of evidence pertaining to intravascular brachytherapy for the treatment of coronary artery restenosis:
- There is insufficient evidence on the safety and effectiveness of implanting radioactive stents to support public funding for this procedure.
- The short- and medium-term data on the safety and effectiveness of catheter-based intravascular brachytherapy for the treatment of coronary artery restenosis is sufficient to warrant interim funding for this procedure.
- A review by MSAC is recommended in three years time to allow for consideration of both longer-term safety and cost-effectiveness data on the procedure, as well as the potential place of evolving techniques in this field (eg drug-coated stents).
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.msac.gov.au/
Year Published:
2002
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Cardiovascular Surgical Procedures
- Costs and Cost Analysis
- Brachytherapy
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.